Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Todd Neale

September 30, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

Todd Neale

September 06, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Leadless CRT a Safe, Effective Way to Deliver Pacing: SOLVE-CRT

Caitlin E. Cox

August 05, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Todd Neale

May 31, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Conference News ISET 2024

AI Tools to Meet Every Need? The Future of Vascular Medicine

Caitlin E. Cox

February 02, 2024

Advertisement

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Little Pre- and Postmarket Testing for Most Recalled CV Devices

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Leadless CRT a Safe, Effective Way to Deliver Pacing: SOLVE-CRT

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

AI-Assisted Look at Coronary Inflammation on CT Refines CV Risk Assessment

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

AI Tools to Meet Every Need? The Future of Vascular Medicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content